Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) announced Thursday that elinzanetant, its experimental therapy for hot flashes, reached the ...

Medically reviewed by Renita White, MD Perimenopause is the transition period when the female body starts to shift from ...

As Bayer awaits an FDA decision on its non-hormonal treatment for hot flashes caused by menopause, it's unveiling new results ...

By incorporating these home remedies and avoiding harmful habits, you can start to restore balance to your hormones, feel ...

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.

Moreover, particularly as many menopausal women have become concerned about the safety of using prescription hormone replacement therapy (HRT) to cool down their hot flashes and related symptoms ...

Citalopram, a selective serotonin reuptake inhibitor, is an effective, well-tolerated agent for the management of hot flashes, a novel study published in the Journal of Clinical Oncology has ...

Click here to get the full newsletter in your inbox, including answers to reader questions and a summary of new scientific ...

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of ...